{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:20:48Z","timestamp":1785903648808,"version":"3.56.0"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Disturbed gut microbiota and associated metabolic dysfunction exist in Psoriasis. Despite the growing use of interleukin-17 inhibitor (anti-IL17) therapy, the effect of anti-IL17 on gut\/skin microbiota function is not fully understood in patients with Psoriasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>Therefore, we explored whether Psoriasis is associated with alterations in selected gut\/skin microbiota in a study cohort, and a longitudinal cohort study to reveal the effects of IL-17A inhibitor treatment on gut microbiota in Psoriasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a case-control study, 14 patients with Psoriasis and 10 age, sex and body mass index-matched Healthy Controls were recruited. Longitudinal mapping of the gut microbiome was performed using 16S rRNA gene sequencing. Mouse models were used to further study and validate the interrelationship between the skin microbiome and the gut microbiome in Psoriasis. PICRUST2 was applied to predict the function of the bacterial community.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In Psoriasis patients, gut microbiota dysbiosis was present with increased heterogeneity: decreased <jats:italic>Bacteroidota<\/jats:italic> and increased <jats:italic>Firmicutes<\/jats:italic> as well as <jats:italic>Actinobacteriota<\/jats:italic> predominating in Psoriasis. <jats:italic>Escherichia-Shigella<\/jats:italic> enrichment was associated with reduction in serum levels of total bile acid and markers in Apoptotic pathways. After IL-17A inhibitor treatment in Psoriasis patients, longitudinal studies observed a trend toward a normal distribution of the gut microbiome and modulation of apoptosis-related metabolic pathways. Results from a mouse model showed dysregulation of the skin microbiota in Psoriasis characterized by <jats:italic>Staphylococcus<\/jats:italic> colonization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The psoriatic gut\/skin microbiota exhibits loss of community stability and pathogen enrichment. IL-17A inhibitors restore microbiota homeostasis and metabolic pathways, reduce pro-inflammatory cytokine expression, and alleviate symptoms in patients with Psoriasis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1344963","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T04:42:16Z","timestamp":1709095336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal\/skin microbiota homeostasis and altered microbiota function"],"prefix":"10.3389","volume":"15","author":[{"given":"Huixia","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.08.015","article-title":"Triggering Psoriasis: The role of infections and medications","volume":"25","author":"Fry","year":"2007","journal-title":"Clin Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18245","article-title":"Management of Psoriasis as a systemic disease: What is the evidence","volume":"182","author":"Korman","year":"2020","journal-title":"Br J Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.10.033","article-title":"Performing skin microbiome research: a method to the madness","volume":"137","author":"Kong","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.03.1501","article-title":"Longitudinal study of the Psoriasis-associated skin microbiome during therapy with ustekinumab in a randomized phase 3b clinical trial","volume":"138","author":"Loesche","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2010.06.006","article-title":"Psoriasis genetics: breaking the barrier","volume":"26","author":"Roberson","year":"2010","journal-title":"Trends Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2016.1166214","article-title":"New insights into the role of T cells in pathogenesis of Psoriasis and psoriatic arthritis","volume":"49","author":"Karczewski","year":"2016","journal-title":"Autoimmunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108537","article-title":"The cutaneous and intestinal microbiome in psoriatic disease","volume":"218","author":"Le","year":"2020","journal-title":"Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14016","article-title":"Targeting the gut-skin axis\u2014Probiotics as new tools for skin disorder management","volume":"28","author":"Sz\u00e1nt\u00f3","year":"2019","journal-title":"Exp Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9060463","article-title":"Gut microbiome in Psoriasis: An updated review","volume":"9","author":"Sikora","year":"2020","journal-title":"Pathogens"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.03.019","article-title":"Relationship between gut microbiota and development of T cell associated disease","volume":"588","author":"Kosiewicz","year":"2014","journal-title":"FEBS Lett"},{"key":"B11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/PTT.S85194","article-title":"Psoriasis and inflammatory bowel disease: Links and risks","volume":"6","author":"Vlachos","year":"2016","journal-title":"Psoriasis (Auckl)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00007","article-title":"Bacterial dysbiosis and translocation in Psoriasis vulgaris","volume":"9","author":"Visser","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg5645","article-title":"A conserved Bacteroidetes antigen induces anti-inflammatory intestinal T lymphocytes","volume":"377","author":"Bousbaine","year":"2022","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109608","article-title":"Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodes","volume":"36","author":"Sano","year":"2021","journal-title":"Cell Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014681118","article-title":"Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation","volume":"118","author":"Hao","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.48","article-title":"The influence of skin microorganisms on cutaneous immunity","volume":"16","author":"Belkaid","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.4103\/jfmpc.jfmpc_709_19","article-title":"The role of gut microbiome in the pathogenesis of Psoriasis and the therapeutic effects of probiotics","volume":"8","author":"Alzahrani","year":"2019","journal-title":"J Fami Med Primary Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020244","article-title":"The gut microbiome in psoriasis and crohn\u2019s disease: is its perturbation a common denominator for their pathogenesis","volume":"10","author":"de Francesco","year":"2022","journal-title":"Vaccines"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201600008","article-title":"The gut-skin axis in health and disease: a paradigm with therapeutic implications","volume":"38","author":"O\u2019Neill","year":"2016","journal-title":"BioEssays"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmic.2020.100016","article-title":"Role of skin and gut microbiota in the pathogenesis of Psoriasis, an inflammatory skin disease","volume":"4","author":"Hsu","year":"2020","journal-title":"Med Microecol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2014.5585","article-title":"Identification of bacterial DNA in the peripheral blood of patients with active Psoriasis","volume":"151","author":"Ram\u00edrez-Bosc\u00e1","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13449","article-title":"IL-17 in inflammatory skin diseases Psoriasis and hidradenitis suppurativa","volume":"201","author":"Fletcher","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41522-023-00420-5","article-title":"Bacteroides uniformis-induced perturbations in colonic microbiota and bile acid levels inhibit TH17 differentiation and ameliorate colitis developments","volume":"9","author":"Yan","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2010.03657.x","article-title":"Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis","volume":"41","author":"Nermes","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.2909","article-title":"Drug survival associated with effectiveness and safety of treatment with guselkumab, ixekizumab, secukinumab, ustekinumab, and adalimumab in patients with psoriasis","volume":"158","author":"Yiu","year":"2022","journal-title":"JAMA Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00849-7","article-title":"Gut microbiome in psoriasis is perturbed differently during secukinumab and ustekinumab therapy and associated with response to treatment","volume":"39","author":"Yeh","year":"2019","journal-title":"Clin Drug Investig"},{"key":"B28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.35541\/cjd.20190847","article-title":"Guideline for the diagnosis and treatment of psoriasis in China (2018 complete edition)","volume":"52","year":"2019","journal-title":"Chin J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13738","article-title":"PASI vs PO-PASI: Patient-Oriented PASI (PO-PASI) is comparable to clinician score PASI","volume":"63","author":"de Oca Pedrosa","year":"2022","journal-title":"Australas J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1746734","article-title":"Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life","volume":"31","author":"Gerdes","year":"2020","journal-title":"J Dermatol Treat"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1000776","article-title":"The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain","volume":"11","author":"Maravilla-Herrera","year":"2023","journal-title":"Front Public Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jid.2021.10.027","article-title":"Bile acids improve psoriasiform dermatitis through inhibition of IL-17A expression and CCL20-CCR6-mediated trafficking of T cells","volume":"142","author":"Shi","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jdermsci.2019.05.007","article-title":"Long-term Western diet intake leads to dysregulated bile acid signaling and dermatitis with Th2 and Th17 pathway features in mice","volume":"95","author":"Prasant Kumar","year":"2019","journal-title":"J Dermatol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2096995","article-title":"Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases","volume":"14","author":"Mahmud","year":"2022","journal-title":"Gut Microbes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40168-018-0533-1","article-title":"Alteration of the cutaneous microbiome in Psoriasis and potential role in Th17 polarization","volume":"6","author":"Chang","year":"2018","journal-title":"Microbiome"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7110550","article-title":"The skin and gut microbiome and its role in common dermatologic conditions","volume":"7","author":"Ellis","year":"2019","journal-title":"Microorganisms"},{"key":"B37","doi-asserted-by":"publisher","first-page":"adv00698","DOI":"10.2340\/actadv.v102.563","article-title":"Long-term safety of secukinumab over five years in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis: update on integrated pooled clinical trial and post-marketing surveillance data","volume":"102","author":"Gottlieb","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109332","article-title":"Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal \u03b3\u03b4 T cells","volume":"36","author":"Dupraz","year":"2021","journal-title":"Cell Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054568","article-title":"Compositional alteration of gut microbiota in psoriasis treated with IL-23 and IL-17 inhibitors","volume":"24","author":"Huang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for prediction of metagenome functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17931","article-title":"Gut microbiota dysbiosis in a cohort of patients with Psoriasis","volume":"181","author":"Hidalgo-Cantabrana","year":"2019","journal-title":"Br J Dermatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/1346-8138.14933","article-title":"Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls","volume":"46","author":"Shapiro","year":"2019","journal-title":"J Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.42288","article-title":"Dysregulation of bile acids, lipids, and nucleotides in psoriatic arthritis revealed by unbiased profiling of serum metabolites","volume":"75","author":"Paine","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.02.003","article-title":"Bioactive lipid mediator profiles in human psoriasis skin and blood","volume":"138","author":"Sorokin","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"23813","DOI":"10.1038\/s41598-021-03396-4","article-title":"Ileal microbial shifts after Roux-en-Y gastric bypass orchestrate changes in glucose metabolism through modulation of bile acids and L-cell adaptation","volume":"11","author":"Dang","year":"2021","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-12-0270-T","article-title":"Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma","volume":"11","author":"Yan","year":"2013","journal-title":"Mol Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.13455","article-title":"Pathological role of excessive DNA as a trigger of keratinocyte proliferation in Psoriasis","volume":"202","author":"Luo","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1038\/s41598-020-59996-z","article-title":"Hyperproliferation is the main driver of metabolomic changes in Psoriasis lesional skin","volume":"10","author":"Pohla","year":"2020","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1159\/000018394","article-title":"Apoptosis in established and healing Psoriasis","volume":"200","author":"Laporte","year":"2000","journal-title":"Dermatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12860-019-0229-9","article-title":"LncRNA MEG3 infuences the proliferation and apoptosis of Psoriasis epidermal cells by targeting miR-21\/caspase-8","volume":"20","author":"Jia","year":"2019","journal-title":"BMC Mol Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2656","article-title":"Involved and uninvolved psoriatic keratinocytes display a resistance to apoptosis that may contribute to epidermal thickness","volume":"97","author":"Eding","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1- phosphate signaling and its role in disease","volume":"22","author":"Maceyka","year":"2012","journal-title":"Trends Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901586","article-title":"Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation","volume":"184","author":"Michaud","year":"2010","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6889com","article-title":"The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing","volume":"21","author":"Serriere-Lanneau","year":"2007","journal-title":"FASEB J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6741-1_10","article-title":"Extracellular and intracellular actions of sphingosine-1-phosphate","volume":"688","author":"Strub","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M004929","article-title":"Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G (\u03b1)i-protein-coupled receptors and the AKT pathway","volume":"51","author":"Cao","year":"2010","journal-title":"J Lipid Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2635","article-title":"Innate immune recognition of the microbiota promotes host-microbial symbiosis","volume":"14","author":"Chu","year":"2013","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bjd.12322","article-title":"Is chronic plaque Psoriasis triggered by microbiota in the skin","volume":"169","author":"Fry","year":"2013","journal-title":"Br J Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2012.12048","article-title":"Skin commensal fungus malassezia and its lipases","volume":"31","author":"Park","year":"2021","journal-title":"J Microbiol Biotechnol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.jid.2023.04.021","article-title":"Resolved psoriasis with abundant oleic acid in stratum corneum exhibits lower T-cell-driven IL-17 signature","volume":"143","author":"El Mahi","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13786","article-title":"Intestinal microbiota profiling and predicted metabolic dysregulation in Psoriasis patients","volume":"27","author":"Chen","year":"2018","journal-title":"Exp Dermatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2647-3","article-title":"A systematic review and meta-analysis on Staphylococcus aureus carriage in Psoriasis, acne and rosacea","volume":"35","author":"Tott\u00e9","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.516302","article-title":"Catabolite control protein E (CcpE) is a LysR-type transcriptional regulator of tricarboxylic acid cycle activity in Staphylococcus aureus","volume":"288","author":"Hartmann","year":"2013","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41396-020-0651-1","article-title":"The gut microbiota contributes to the development of Staphylococcus aureus-induced mastitis in mice","volume":"14","author":"Hu","year":"2020","journal-title":"ISME J"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/538546","article-title":"Nonprofessional phagocytic cell receptors involved in staphylococcus aureus internalization","volume":"2014","author":"Alva-Murillo","year":"2014","journal-title":"BioMed Res Int"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.11.6373-6382.2002","article-title":"Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival","volume":"70","author":"Somerville","year":"2002","journal-title":"Infect Immun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1411077111","article-title":"Metabolic sensor governing bacterial virulence in Staphylococcus aureus","volume":"111","author":"Ding","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/nu14183687","article-title":"Short chain fatty acids (SCFAs) are the potential immunomodulatory metabolites in controlling staphylococcus aureus-mediated mastitis","volume":"14","author":"Akhtar","year":"2022","journal-title":"Nutrients"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15951","article-title":"The gut microbiome alterations in allergic and inflammatory skin diseases\u2013an update","volume":"34","author":"Polkowska-Pruszy\u0144ska","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.12932\/AP0803","article-title":"The potential impact of gut microbiota on your health: Current status and future challenges","volume":"34","author":"Sirisinha","year":"2016","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","author":"Huttenhower","year":"2012","journal-title":"Nature"},{"key":"B74","article-title":"The role of intestinal microbiota and the immune system","volume":"17","author":"Purchiaroni","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3920\/BM2012.0066","article-title":"Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota","volume":"5","author":"Miyazaki","year":"2014","journal-title":"Benef Microbes"},{"key":"B76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.micpath.2019.03.030","article-title":"Immunomodulatory molecules regulate adhesin gene expression in Staphylococcus aureus: Effect on bacterial internalization into bovine mammary epithelial cells","volume":"131","author":"Frutis-Murillo","year":"2019","journal-title":"Microb Pathog"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4110\/in.2019.19.e9","article-title":"Short-chain fatty acids inhibit staphylococcal lipoprotein-induced nitric oxide production in murine macrophages","volume":"19","author":"Park","year":"2019","journal-title":"Immune Netw"},{"key":"B78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1440-0960.2012.00878.x","article-title":"A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis","volume":"53","author":"Kapila","year":"2012","journal-title":"Australas J Dermatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.jaci.2018.01.019","article-title":"Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration","volume":"141","author":"Baurecht","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15390","article-title":"The role of the skin microbiome in atopic dermatitis: A systematic review","volume":"177","author":"Bjerre","year":"2017","journal-title":"Br J Dermatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/all.12549","article-title":"Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria","volume":"70","author":"Nylund","year":"2015","journal-title":"Allergy"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1174331","article-title":"Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study","volume":"10","author":"Xue","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814322","article-title":"The interaction between the host genome, epigenome, and the gut-skin axis microbiome in atopic dermatitis","volume":"24","author":"Pess\u00f4a","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15530","article-title":"Diversity analysis of gut microbiota between healthy controls and those with atopic dermatitis in a Chinese population","volume":"48","author":"Ye","year":"2021","journal-title":"J Dermatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612856","article-title":"Unique gut microbiome signatures among adult patients with moderate to severe atopic dermatitis in southern Chinese","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159539","article-title":"Intestinal microbiota promotes Psoriasis-like skin infammation by enhancing Th17 response","volume":"11","author":"Zakostelska","year":"2016","journal-title":"PloS One"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14661","article-title":"Immunosuppressive efect of the gut microbiome altered by high-dose tacrolimus in mice","volume":"18","author":"Zhang","year":"2018","journal-title":"Am J Transplant"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000332","article-title":"Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases","volume":"21","author":"Huang","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1053\/j.gastro.2010.08.049","article-title":"A pyrosequencing study in twins shows that GI microbial profiles vary with inflammatory bowel disease phenotypes","volume":"139","author":"Willing","year":"2010","journal-title":"Gastroenterology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mnfr.201600528","article-title":"A safflower oil based highfat\/high-sucrose diet modulates the gut microbiota and liver phospholipid profiles associated with early glucose intolerance in the absence of tissue inflammation","volume":"61","author":"Danneskiold-Sams\u00f8e","year":"2017","journal-title":"Mol Nutr Food Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anaerobe.2015.03.008","article-title":"Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization","volume":"34","author":"Zhang","year":"2015","journal-title":"Anaerobe"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1288525","article-title":"Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Microbiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41396-019-0364-5","article-title":"Defining the role of Parasutterella, a previously uncharacterized member of the core gut microbiota","volume":"13","author":"Ju","year":"2019","journal-title":"ISME J"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13858","article-title":"Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis","volume":"45","author":"Acharya","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.000269","article-title":"Hypoxanthine is a checkpoint stress metabolite in colonic epithelial energy modulation and barrier function","volume":"293","author":"Scott Lee","year":"2018","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1802866","article-title":"Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health","volume":"12","author":"Mukherjee","year":"2020","journal-title":"Gut Microbes"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082171","article-title":"An insight on the possible association between inflammatory bowel disease and biologic therapy with IL-17 inhibitors in psoriasis patients","volume":"15","author":"Orzan","year":"2023","journal-title":"Pharmaceutics"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14281","article-title":"Parasutterella, in association with irritable bowel syndrome and intestinal chronic inflammation","volume":"33","author":"Chen","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812996","article-title":"Altered fecal metabolomics and potential biomarkers of psoriatic arthritis differing from rheumatoid arthritis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/nu15081952","article-title":"Dose-response efficacy and mechanisms of orally administered bifidobacterium breve CCFM683 on IMQ-induced psoriasis in mice","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.984016","article-title":"IL-17 and IL-22 are pivotal cytokines to delay wound healing of S. aureus and P. aeruginosa infected skin","volume":"13","author":"Lecron","year":"2022","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13115","article-title":"IL-17A promotes neutrophilic inflammation and disturbs acute wound healing in skin","volume":"26","author":"Takagi","year":"2017","journal-title":"Exp Dermatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.368","article-title":"Reduced Il17a expression distinguishes a Ly6clomhciihi macrophage population promoting wound healing","volume":"133","author":"Rodero","year":"2013","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1344963\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T04:42:20Z","timestamp":1709095340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1344963\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":103,"alternative-id":["10.3389\/fimmu.2024.1344963"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1344963","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"article-number":"1344963"}}